Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
11/27/2003 | CA2486147A1 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
11/27/2003 | CA2485969A1 Carotene synthase gene and uses therefor |
11/27/2003 | CA2485847A1 Glucan-based vaccines |
11/27/2003 | CA2485453A1 Polypeptide antigen inducing hiv neutralizing antibodies |
11/27/2003 | CA2483285A1 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
11/27/2003 | CA2390972A1 Bovine viral diarrhea virus (bvdv) p80 and p80.delta.50 proteins as inducers of cell apoptosis |
11/27/2003 | CA2383607A1 Bovine viral diarrhea virus (bvdv) p80 and p80.delta.50 proteins as inducers of cell apoptosis in vitro |
11/26/2003 | EP1365243A1 Immunoassay method/equipment, biological component measurable toilet, anti-albumin monoclonal antibody, cell strain producing the same, and albumin detection kit |
11/26/2003 | EP1365032A1 Marker molecules associated with lung tumors |
11/26/2003 | EP1365022A1 Adiponectin-associated protein |
11/26/2003 | EP1364969A2 Human tissue factor related DNA segments, polypeptides and antibodies |
11/26/2003 | EP1364965A1 Slit1 and MEGF4 isoforms and uses thereof |
11/26/2003 | EP1364963A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
11/26/2003 | EP1364657A1 Remedies for tumor in hematopoietic organs |
11/26/2003 | EP1364205A1 Production of a monoclonal antibody by a transgenic avian |
11/26/2003 | EP1364025A1 A novel gene bn01 mapping to chromosome 16q24.3 |
11/26/2003 | EP1364023A2 Method of diagnosing and treating cartilage disorders |
11/26/2003 | EP1364022A2 Human leucine-rich repeat containing protein, hlrrbm1, expressed predominately in bone marrow |
11/26/2003 | EP1364021A2 Compositions and methods relating to colon specific genes and proteins |
11/26/2003 | EP1364019A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
11/26/2003 | EP1364018A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
11/26/2003 | EP1364017A2 Inflammation related g-protein coupled receptor |
11/26/2003 | EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses |
11/26/2003 | EP1363998A1 Novel human poly(a)polymerase gamma (pap gamma) |
11/26/2003 | EP1363996A2 Epothilone resistant cell lines |
11/26/2003 | EP1363950A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors |
11/26/2003 | EP1363942A2 Polypeptide from a hdm2 protein specific murine alpha/beta t-cell receptors, nucleic acids coding for the above and use thereof |
11/26/2003 | EP1363941A2 Histidine phosphatase interacting protein of 120 kd |
11/26/2003 | EP1363940A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
11/26/2003 | EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof |
11/26/2003 | EP1363931A2 Methods to generate and identify monoclonal antibodies to a large number of human antigens |
11/26/2003 | EP1363674A2 Agents and methods for treating pain |
11/26/2003 | EP1363666A1 Methods for treating disease states comprising administration of low levels of antibodies |
11/26/2003 | EP1363653A2 Methods and compositions for enhancing angiogenesis |
11/26/2003 | EP1363643A2 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
11/26/2003 | EP1363528A2 Methods for diagnosing and treating heart disease |
11/26/2003 | EP0871492B1 Mesothelium antigen and methods and kits for targeting it |
11/26/2003 | EP0859627B1 Mimicking peptides in cancer therapy |
11/26/2003 | EP0759693B1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS |
11/26/2003 | EP0705278B1 Apoptose inhibitor |
11/26/2003 | EP0635054B1 Mammalian melanocyte stimulating hormone receptors and uses |
11/26/2003 | EP0590058B1 HUMANIZED Heregulin ANTIBODy |
11/26/2003 | CN1458977A Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug |
11/26/2003 | CN1458976A Permeases 2,5-DKG |
11/26/2003 | CN1458936A HIV peptides from Tat, Rev and Nef conserved regions and their application as E.G. vaccine components |
11/26/2003 | CN1458171A Antigen of specificalloy resisting new epidemic coronary virus strain and its producing method |
11/26/2003 | CN1458170A New human protein with cancer inhibiting function and its encoding sequence |
11/26/2003 | CN1458169A New human protein with function of improving mouse NIH/3T3 cell transformation and its encoding sequence |
11/26/2003 | CN1457884A Double virus inactivating/removing method for venous injection human immune globulin |
11/26/2003 | CN1128878C Coding sequence of human methionine sulfoxide rductase, its encoded polypeptide and its preparing method |
11/26/2003 | CN1128812C Preparation of egg specific antibody by sedimentation-filtering-sulfurphilic chromatography process |
11/25/2003 | US6653459 Isolated nucleic acid encoding a polypeptide of given sequence; use in producing glycoproteins with minimal and uniform sugar residues; low antigenicity; side-effect reduction of drugs |
11/25/2003 | US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same |
11/25/2003 | US6653447 ULBP DNA and polypeptides |
11/25/2003 | US6653446 Nucleotide sequences which code enzymatic polypeptide for use in treatment of gout, kidney, blood and preferential genetic disorders |
11/25/2003 | US6653445 Chemotactic cytokine V (CCV); isolated protein of given sequence; use in diagnostics and as anti-viral or anti-tumor agent |
11/25/2003 | US6653443 Viral infectivity factor protein (Vif) antagonist that binds to the multimerization domain within a Vif protein in a cell and inhibits Vif protein; treating acquired immunodeficiency syndrome (AIDS) |
11/25/2003 | US6653442 Protegrins |
11/25/2003 | US6653287 Use of leukemia inhibitory factor and endothelin antagonists |
11/25/2003 | US6653116 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
11/25/2003 | US6653104 Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells |
11/25/2003 | US6653103 For inhibiting export of nucleic acids from nucleus to cytoplasm of a cell |
11/25/2003 | US6653102 Nucleotide sequence coding preferential protein for use in the treatment of nervous system disorders |
11/25/2003 | US6653074 Methods for identifying agents which affect cellular morphology, locomotion and death |
11/25/2003 | US6653072 Improving expression of a protein encoded by DNA substrate by assembling oligonucleotides into recombinant nucleic acids and using it to transform cells; recursive sequence recombination |
11/25/2003 | US6653068 Generation of specific binding partners binding to (poly)peptides encoded by genomic DNA fragments or ESTs |
11/25/2003 | US6652863 Creating fusion compounds by linking to auto-antigenic sequences |
11/25/2003 | US6652858 Administering an OX-2 protein or a nucleic acid encoding it to preventing graft rejection, fetal loss, autoimmune disease, and allergies; immunosuppressants; gene therapy |
11/25/2003 | US6652857 Methods for producing avian verotoxin antitoxin |
11/25/2003 | US6652856 Method for the treatment of fibrosis |
11/25/2003 | US6652855 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist |
11/25/2003 | US6652854 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening |
11/25/2003 | US6652853 Useful for treating patients with colorectal cancer and gastric carcinomas; particularly useful for treating patients who have tumors that are resistant to one or more chemotherapeutic agents and/or have metastasized. |
11/25/2003 | US6652852 Specificity for CD20 antigen |
11/25/2003 | CA2194166C Multi-stage cascase boosting vaccine |
11/25/2003 | CA2100860C A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins |
11/20/2003 | WO2003096022A2 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
11/20/2003 | WO2003095971A2 Posh nucleic acids, polypeptides and related methods |
11/20/2003 | WO2003095968A2 Method for simultaneously detecting an antigen and an antibody of an infectious microorganism |
11/20/2003 | WO2003095626A2 Purified composition of bispecific molecules and methods of production |
11/20/2003 | WO2003095610A2 Directed evolution method of generating enhanced folding polypeptide variants |
11/20/2003 | WO2003095493A2 Toxin-related antibodies with antimicrobial and antiviral activity |
11/20/2003 | WO2003095492A1 Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
11/20/2003 | WO2003095491A2 Antibody screening libraries |
11/20/2003 | WO2003094966A1 Arterialization agent and antiarterialization agent |
11/20/2003 | WO2003094859A2 Epha2 monoclonal antibodies and methods of use thereof |
11/20/2003 | WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport |
11/20/2003 | WO2003054012A3 Leptin proteins |
11/20/2003 | WO2003051927A3 Production of f(ab')2 fragments in mammalian cells |
11/20/2003 | WO2003050287A3 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase |
11/20/2003 | WO2003045993A3 Protein biopolymer markers predictive of type ii diabetes |
11/20/2003 | WO2003044172A3 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
11/20/2003 | WO2003042401A3 Novel chromophores/fluorophores and methods for using the same |
11/20/2003 | WO2003042357A3 Enzymes |
11/20/2003 | WO2003040183A3 Compounds for the diagnosis/prevention/treatment of alzheimer's disease |
11/20/2003 | WO2003039459A3 Viral vector production methods and compositions |
11/20/2003 | WO2003020909A3 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
11/20/2003 | WO2003019136A3 Methods for inhibiting angiogenesis |
11/20/2003 | WO2003016506A3 Secreted proteins |
11/20/2003 | WO2003016468A3 Antagonistic anti-htnfsf13b human antibodies |